Witryna11 kwi 2024 · IM Cannabis Corp. (IMCC) Reports Q3 Loss, Misses Revenue Estimates. IM Cannabis Corp. (IMCC) delivered earnings and revenue surprises of 16.67% and … WitrynaIM Cannabis Corp. analyst ratings, historical stock prices, earnings estimates & actuals. IMCC updated stock price target summary.
IM Cannabis Corp. Reports Earnings Results for the Full Year …
WitrynaView today's IMCC stock price, trade commission-free, and discuss IMCC stock updates with the investor community. ... IM Cannabis Corp. (IMCC) Q4 2024 Earnings Call … WitrynaIM Cannabis Corp. (IMCC) CEO Oren Shuster on Q3 2024 Results - Earnings Call Transcript Seeking Alpha - Nov 14, 2024, 3:11PM IM Cannabis Corp. (IMCC) Q3 … lithos vs petros
IMCC IM Cannabis Corp. Analyst Estimates & Rating – WSJ
WitrynaIM Cannabis Corp is a Canada-based international medical cannabis company. It offers government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. The majority of its revenues are generated from sales of medical cannabis products to customers in Israel and … WitrynaEarnings for IM Cannabis (IMCC) Earnings in 2024 (TTM): -$34.38 M. According to IM Cannabis's latest financial reports the company's current earnings (TTM) are -$34.38 … WitrynaIMCC is an international medical cannabis company, and a well-known Israeli brand of medical cannabis products. In Europe, IMCC is establishing a fully operational, vertically integrated medical cannabis business spearheaded by its distribution arm in Germany and augmented by strategic agreements with certified EU-GMP Standard suppliers, … lithotabs